<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>NovaMed Sales and Customer Performance Analysis</title>
  <style>
    body {
      margin: 0;
      font-family: 'Segoe UI', sans-serif;
      background-color: #eef6f9;
      transition: background-color 0.3s, color 0.3s;
    }

    .header {
      background-color: #3c613f;
      color: white;
      padding: 30px;
      text-align: center;
    }

    .header-top {
      display: flex;
      justify-content: flex-start;
      margin-bottom: 10px;
    }

    .home-button {
      background-color: #70eec4;
      color: #003845;
      text-decoration: none;
      padding: 8px 16px;
      border-radius: 6px;
      font-size: 1rem;
      font-weight: 500;
      transition: background-color 0.3s ease;
    }

    .home-button:hover {
      background-color: #4db4a5;
      color: white;
    }

    .header h1 {
      margin: 0;
      font-size: 2.2rem;
    }

    .container {
      max-width: 1200px;
      margin: 40px auto;
      padding: 20px;
    }

    .embed-box, .video-box {
      position: relative;
      width: 100%;
      padding-top: 56.25%;
      border-radius: 12px;
      overflow: hidden;
      box-shadow: 0 0 15px rgba(0, 0, 0, 0.15);
      margin-bottom: 40px;
    }

    iframe {
      position: absolute;
      top: 0; left: 0;
      width: 100%;
      height: 100%;
      border: none;
    }

    .dark-mode .home-button {
      background-color: #018f70;
      color: #fff;
    }

    .toggle-theme {
      text-align: center;
      margin: 20px auto;
    }

    .toggle-theme button {
      padding: 10px 20px;
      border: none;
      border-radius: 8px;
      background-color: #00b679;
      color: white;
      font-size: 1rem;
      cursor: pointer;
    }
  </style>
</head>
<body>

<div class="header">
  <div class="header-top">
    <a href="index.html" class="home-button">HOME</a>
  </div>
  <h1>NovaMed Sales and Customer Performance Analysis</h1>
  <p>A Comprehensive Review of Financial and Provider Metrics</p>
</div>

<div class="container">

 <!-- Power BI Embed -->
<div class="embed-box">
  <iframe title="Medical Metrics Dashboard"
    src="https://app.powerbi.com/reportEmbed?reportId=3f4e77cb-806b-4b5b-b56b-71115aa13cfe&autoAuth=true&ctid=79401934-75b9-4f0a-b2e1-6bc24af8c9c9"
    allowFullScreen="true">
  </iframe>
</div>

  <!-- Video Presentation Embed -->
  <div class="video-box">
    <iframe title="Healthcare Presentation Video"
      src="https://www.youtube.com/embed/YOUR_VIDEO_ID"
      allowfullscreen>
    </iframe>
  </div>

  <!-- PDF Link -->
  <div style="text-align: center; margin-top: 20px;">
    <a href="Healthcare_Economics_Report.pdf" target="_blank"
       style="background-color: #00b661; color: white; padding: 10px 20px; border-radius: 6px; text-decoration: none; font-weight: 600;">
      View PDF Presentation
    </a>
  </div>

  <!-- Power BI Direct Link -->
  <div style="text-align: center; margin-top: 20px;">
    <a href="https://app.powerbi.com/reportEmbed?reportId=YOUR_REPORT_ID&autoAuth=true&ctid=YOUR_CTID&actionBarEnabled=true" 
       target="_blank" 
       style="color: #00b652; text-decoration: none; font-weight: 600;">
      ðŸ”— Open in Power BI
    </a>
  </div>

<!-- Dashboard Snippets Section -->
<div style="margin-top: 50px;">
  <h2 style="text-align: center; color: #00b652;">Dashboard Highlights</h2>
  <div style="display: flex; flex-wrap: wrap; justify-content: space-between; gap: 20px; margin-top: 20px;">
    
    <!-- Snippet 1 -->
    <div style="flex: 1; min-width: 280px; background: #ffffff; border-radius: 10px; box-shadow: 0 0 10px rgba(0,0,0,0.1); overflow: hidden;">
      <img src="images/Capture 1.PNG" alt="Detail" style="width: 100%; display: block;">
      <div style="padding: 15px; color: #004931;">
        <strong>Detail</strong><br>
        This Dashboard provides a comprehensive overview of healthcare billing and costs across various cities in the United Kingdom, detailing average expenses, procedure-specific billing, departmental breakdowns, and diagnosis-related services.
      </div>
    </div>

    <!-- Snippet 2 -->
    <div style="flex: 1; min-width: 280px; background: #ffffff; border-radius: 10px; box-shadow: 0 0 10px rgba(0,0,0,0.1); overflow: hidden;">
      <img src="images/Capture 2.PNG" alt="Trend" style="width: 100%; display: block;">
      <div style="padding: 15px; color: #004927;">
        <strong>Trend</strong><br>
        The Medical Metrics Trend dashboard provides a comprehensive overview of billing amounts and trends across months, weeks, quarters, and departments, highlighting average billing per visit and year-over-year changes.
      </div>
    </div>

  </div>
</div>


  <!-- Info Box -->
<!-- About Section -->
<div class="about-section">
  <h2>Detail: Setting the Scene and Unveiling the Purpose:</h2>
  <p>
    Imagine NovaMed Solutions as a pioneering ship navigating the vast ocean of the pharmaceutical industry, delivering essential drugs to customers worldwide. This Top/Bottom Analysis dashboard is our captain's log, chronicling the company's performance across key dimensions like time, products, customers, and geography. The purpose behind this data isn't just to tally numbers; it is to reveal the "why" driving success or setbacks. Why do some areas generate towering profits while others barely stay afloat? By dissecting top performers, the peaks that propel growth, and bottom performers, the valleys signalling risks, we uncover actionable truths. These insights empower leaders to optimise resources, mitigate weaknesses, and steer toward sustainable expansion. At its core, the data tells a story of efficiency and opportunity. With a total profit of Â£58.5M from Â£71.3M in revenue, NovaMed demonstrates strong fundamentals, but hidden patterns in the numbers highlight where strategic adjustments could unlock even greater potential. Let's dive into the voyage, section by section, to decode the meanings and draw insights.
  </p>

    <h2>Data Dictionary</h2>
    <p>The data dictionary includes three datasets: <Bold>Customer_Table</Bold>, <Bold>Drug_Lookup</Bold>, and <Bold>Fact_Table</Bold>.
    <ul>
      <li><strong>Customer_Table:</strong> This dataset contains customer information, including the customer ID, which is unique to each customer. FirstName, LastName, Age, Gender, Country, OtherCustomerInf, indicating whether the customer is new, frequent, or preferred. And also the Images, with file paths to images related to the customer.</li>
      <li><strong>Drug_Lookup:</strong> This is a product sales record, and each row represents one drug, and each column describes a different property of that drug. The first column is the DrugID, which is a unique identifier used to identify a drug in the database. The second column is Regulatory_ComplianceID, which is also a unique identifier from the regulatory or compliance authority. The third column is the DrugName, then followed by the UnitSalesPrice, CostOfProduction, and lastly the Treats column, which talks about the illness, infection, or medical condition the drug is intended to treat.</li>
      <li><strong>Fact_Table:</strong> This dataset contains sales transactions, starting with the SalesID, followed by the DrugID, then the CustomerID, UnitSold, Sales_Date, and Buyer_Type, which segments sales between wholesale and retail buyers.</li>
    </ul>
    </p>

      <h2>Navigating the Depths and Exploring the Data, Meanings, and Insights</h2>
      <p>Our journey begins with the overarching metrics, the compass guiding the entire operation. NovaMed has moved 269K units, incurring a modest Cost of Goods Sold (COGS) of Â£13M while generating Â£71.3M in revenue. This culminates in a robust Â£58.5M profit and an exceptional 82% profit margin. The meaning here is clear: pharmaceuticals offer high markups, and NovaMed excels at controlling costs, likely through efficient supply chains or premium pricing on life-saving drugs. Yet, the insight is twofold: this high margin (far above industry averages of 20-40% for generics) signals a competitive edge in branded or speciality meds, but it also warns of vulnerability to cost inflation or regulatory changes. To sustain this, the company should prioritise supplier diversification and innovation in high-margin products.</p>
      <p>Sailing into time-based performance, we first examine profit by week type. Weekdays dominate with Â£43.3M in profit, dwarfing weekends at Â£15.2M, a staggering 64.9% decline. <Bold>Why this disparity?</Bold> Pharmaceuticals are often tied to professional healthcare routines, like doctor visits or B2B orders during business hours, leaving weekends reliant on emergency or retail sales. <strong>The insight:</strong> this reveals untapped potential in consumer-direct channels. By launching weekend promotions, telehealth tie-ins, or over-the-counter pushes, NovaMed could bridge the gap, potentially adding millions to the bottom line without overhauling operations.</p>
      <p>Next, quarterly profits show subtle shifts: Q3 at Â£15.1M dips slightly to Â£14.0M in Q4 (a 4.0% drop), with earlier quarters (Q1 and Q2) hovering around similar levels based on bar heights. This pattern suggests seasonal influences, perhaps holiday slowdowns or end-of-year budget constraints in healthcare spending. The meaning behind these numbers is operational predictability: small fluctuations indicate stable demand, but the Q4 dip could stem from inventory stockpiling or delayed reimbursements. 
      <strong>Insight:</strong> Forward-planning is key; implementing predictive analytics for quarter-end surges could smooth revenues and prevent minor dips from compounding.
  <img src="images/Novamed1.PNG" alt="Example Note" style="max-width: 100%; margin-top: 15px;"> </p>
  <p>
    Zooming out to yearly profits paints a more dramatic picture: 2023 towers at Â£50.5M, but 2024 plummets to Â£2.7M, followed by Â£3.5M in 2025. <bold>Why such a cliff?</bold> This could reflect external shocks, like post-pandemic market saturation, increased competition from generics, or regulatory hurdles or internal factors such as R&D investments draining short-term gains. The numbers mean NovaMed once rode a wave of high growth but now faces headwinds, with profits shrinking to fractions of prior peaks. 
    <bold>Insight:</bold> This is a red flag for long-term viability; an urgent root-cause analysis (e.g., via market research or financial audits) is essential, alongside diversification into emerging therapies to reverse the trend and rebuild toward 2023 levels.
  </p>
</div>

<!-- Optional: Dark Mode Toggle -->
<div class="toggle-theme">
  <button onclick="document.body.classList.toggle('dark-mode')">Toggle Dark Mode</button>
</div>

</body>
</html>